| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 94825-17-9 | D-ALA-GLY-PHE-D-LEU ACETATE SALT; D-ALA-GLY-PHE-D-LEU ACETATE SALT; DES-TYR1 (D-ALA2 D-LEU5)-ENKEPHALIN ACE; DES-TYR1, D-ALA2, D-LEU5-ENKEPHALIN; des-tyrosine1,(D-alanine2,D-leucine5)enkephalin; [des-Tyr1, D-Ala2, D-Leu5]-Enkephalin acetate salt; D-Ala-Gly-Phe-D-Leu |  | C22H34N4O7 | 詳情 | 供應商 | |
| 87553-74-0 | H-D-TYR-OTBU; D-TYROSINE-T-BUTYL ESTER; D-TYROSINE-OTBU; H-D-TYR-OTBU |  | C13H19NO3 | 詳情 | 供應商 | |
| 255063-98-0 | UCM 17197 |  | C15H17ClN4O | 詳情 | 供應商 | |
| 201147-53-7 | 無 | 詳情 | 供應商 | |||
| 918311-87-2 | (3-Triphenylmethylaminomethyl)pyridine; (3-Triphenylmethylaminomethyl)pyridine; UCL 2077; N-Trityl-3-pyridinemethanamine |  | C25H22N2 | 詳情 | 供應商 | |
| 201147-19-5 | UCL 1684 DITRIFLUOROACETATE HYDRATE; UCL 1684 DITRIFLUOROACETATE HYDRATE; 6,12,19,20,25,26-hexahydro- 5,27:13,18:21,24-trietheno-11,7-metheno-7h-dibenzo[b,m][1,5,12,16]tetraazacyclotricosine-5,13-diium ditrifluoroacetate hydrate; 6,12,19,20,25,26-hexahydro- 5,27:13,18:21,24-Trietheno-11,7-metheno-7H-dibenzo[b,m][1,5,12,16]tetraazacyclotricosine-5,13-diium hydrate ditrifluoroacetate; UCL 1684 hydrate ditrifluoroacetate |  | C34H30N4.H2O | 詳情 | 供應商 | |
| 79586-22-4 | 泛素; 泛素 | UBIQUITIN; MET-GLN-ILE-PHE-VAL-LYS-THR-LEU-THR-GLY-LYS-THR-ILE-THR-LEU-GLU-VAL-GLU-PRO-SER-ASP-THR-ILE-GLU-ASN-VAL-LYS-ALA-LYS-ILE-GLN-ASP-LYS-GLU-GLY-ILE-PRO-PRO-ASP-GLN-GLN-ARG-LEU-ILE-PHE-ALA-GLY-LYS-GLN-LEU-GLU-ASP-GLY-ARG-THR-LEU-SER-ASP-TYR-ASN-ILE-GLN-LYS-GLU-SER-THR-LEU-HIS-LEU-VAL-LEU-ARG-LEU-ARG-GLY-GLY-H (ALDEHYDE); UBIQUITIN ALDEHYDE; UBIQUITIN ALDEHYDE (HUMAN); UBIQUITIN, BOVINE; UB-CHO, BOVINE; UB-H; UBIQUITIN; UBIQUITIN C-TERMINAL ALDEHYDE, BOVINE | 無 | NULL | 詳情 | 供應商 |
| 234757-41-6 | U-99194 MALEATE | 無 | C17H27NO2C4H4O4 | 詳情 | 供應商 | |
| 91183-98-1 | 5′-二磷酸尿嘧啶核苷-N-乙酰半乳糖胺二鈉鹽; 5′-二磷酸尿嘧啶核苷-N-乙酰半乳糖胺二鈉鹽 | UDP-ALPHA-D-N-ACETYLGLUCOSAMINE, DISODIUM SALT; UDPAG; UDPAG SODIUM SALT; UDP-ALPHA-D-ACETYLGLUCOSAMINE, DISODIUM SALT; UDP-ALPHA-D-N-ACETYL-GLUCOSAMINE; UDP-ALPHA-D-N-ACETYLGLUCOSAMINE, DISODIUM SALT; UDP-GLCNAC, 2NA; UDP-GLCNAC, NA2; UDP-N-ACETYLGLUCOSAMINE DISODIUM SALT |  | C17H25N3Na2O17P2 | 詳情 | 供應商 |
| 66513-28-8 | INDANOMYCIN FROM STREPTOMYCES*ANTIBIOTIC US; 2h-pyran-2-aceticacid,6-(1-ethyl-4-(1-ethyl-2,3,3a,4,5,7a-hexahydro-4-(1h-pyr; 3-alpha,beta,4-beta,5-beta(1e(2s*(s*),5r*,6s*),3e),7a-alpha))-(1s-(1-alph; 5-dimethyl-rol-2-ylcarbonyl)-1h-inden-5-yl)-3-butadienyl)tetrahydro-alpha; antibioticx14547; antibioticx14547a; x14547; x14547a; INDANOMYCIN FROM STREPTOMYCES*ANTIBIOTIC US |  | C31H43NO4 | 詳情 | 供應商 | |
| 78132-48-6 | 尿苷-5' -二磷酸葡萄糖酸三胺鹽; 尿苷-5' -二磷酸葡萄糖酸三胺鹽 | UDPGA TRIAMMONIUM SALT; URIDINE-DIPHOSPHATE-GLUCURONIC ACID TRIAMMONIUM SALT; URIDINE 5'-DIPHOSPHOGLUCURONIC ACID TRIAMMONIUM SALT; URIDINE[5']DIPHOSPHO[1]-ALPHA-D-GLUCOPYRANOSURONIC ACID TRIAMMONIUM SALT; UDPGA; UDPGA TRIAMMONIUM SALT; URIDINE 5'-DIPHOSPHOGLUCURONIC ACID*TRIA MMONIUM; udp-glca; UDP-GlcA, UDPGA, Uridine-diphosphate-glucuronic acid triammonium salt, Uridine[5μ]diphospho[1]-α-D-glucopyranosuronic acid triammonium salt |  | C15H31N5O18P2 | 詳情 | 供應商 |
| 58069-83-3 | UREA (13C, 15N2); UREA (13C, 15N2); UREA-13C-15N2, 99 ATOM % 13C, 99 ATOM % 15N |  | 13CH4(15N)2O | 詳情 | 供應商 | |
| 40685-78-7 | 4-UREIDO-BENZENESULFONYL CHLORIDE |  | C7H7ClN2O3S | 詳情 | 供應商 | |
| 87151-85-7 | 螺朵林; 螺朵林 | U-62066 (SPIRADOLINE MESYLATE) K-OPIOID AGONIST; U-62066 (SPIRADOLINE MESYLATE) K-OPIOID AGONIST; Spiradoline; (±)-(5α,7α,8β)-3,4-dichloro-n-methyl-n-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]benzeneacetamide mesylate salt; Spiradoline mesylate salt, (±)-(5α,7α,8β)-3,4-Dichloro-N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]benzeneacetamide mesylate salt; Benzeneacetamide, 3,4-dichloro-N-methyl-N-(7-(1-pyrrolidinyl)-1-oxaspiro(4,5)dec-8-yl)-, (5alpha,7alpha,8beta)-(+-)-; Espiradolina; Espiradolina [spanish]; Spiradolinum |  | C22H30Cl2N2O2.CH4O3S | 詳情 | 供應商 |
| 66835-73-2 | VAL-ALA-PRO-GLY ACETATE SALT; VAL-ALA-PRO-GLY ACETATE SALT; val-ala-pro-gly acetate; valyl-alanyl-prolyl-glycine |  | C17H30N4O7 | 詳情 | 供應商 | |
| 62354-43-2 | D-纈氨酰-L-亮氨酰-L-賴氨酰-對-硝基苯胺二鹽酸鹽; S2251; D-纈氨酰-L-亮氨酰-L-賴氨酰-對-硝基苯胺二鹽酸鹽; | D-VAL-LEU-LYS P-NITROANILIDE DIHYDROCHLORIDE; H-D-VAL-LEU-LYS-PNA 2 HCL; D-VAL-LEU-LYS-PNA 2HCL; D-VAL-LEU-LYS-PNA DIHYDROCHLORIDE; D-VAL-LEU-LYS P-NITROANILIDE DIHYDROCHLORIDE; D-VALYL-L-LEUCYL-L-LYSINE-4-NITROANILIDE 2HCL; D-VALYL-L-LEUCYL-L-LYSINE 4-NITROANILIDE DIHYDROCHLORIDE; D-Val-Leu-Lys 4-nitroanilide dihydrochloride; D-Val-Leu-Lys-pan dihydrochloride |  | C23H40Cl2N6O5 | 詳情 | 供應商 |
| 252256-43-2 | SER-GLU-VAL-LYS-VAL-ASP-ALA-GLU-PHE-ARG | (VAL671)-AMYLOID BETA/A4 PROTEIN PRECURSOR770 (667-676); H-SER-GLU-VAL-LYS-VAL-ASP-ALA-GLU-PHE-ARG-OH; SER-GLU-VAL-LYS-VAL-ASP-ALA-GLU-PHE-ARG; [VAL671]-A4 PROTEIN PRECURSOR 770 FRAGMENT 667-676 TRIFLUOROACETATE SALT; [VAL671]-AMYLOID B/A4 PROTEIN PRECURSOR 770 FRAGMENT 667-676 TRIFLUOROACETATE SALT; (VAL671)-AMYLOID BETA/A4 PROTEIN PRECURSOR770 (667-676); (VAL671)-APP770 (667-676); (VAL671)-AMYLOID BETA/A4 PROTEIN*PRECURSOR 770 FRAG; [val671]-amyloid β/a4 precursor protein 770 fragment 667-676 trifluoroacetate salt |  | C51H82N14O18 | 詳情 | 供應商 |
| 61114-01-0 | VANADYL 3,10,17,24-TETRA-TERT-BUTYL-1,8,15,22-TETRAKIS(DIMETHYLAMINO)-29H-PHTHALOCYANINE; VANADYL 3,10,17,24-TETRA-TERT-BUTYL-1,8,15,22-TETRAKIS(DIMETHYLAMINO)-29H-PHTHALOCYANINE; Vanadyl 3,10,17,24-tetra-tert-butyl-1,8,15,22-tetrakis(dimethylamino)-29H,31H-phthalocyanine; vanadyl tetra-T-butyl-tetrakis(dimethyl-amino)-29; VANADYL TETRA-T-BUTYL-TETRAKIS(DIMETHYL- AMINO)-29H,31H-PHTHALOCYANINE; vanadyl tetrabutyltetrakis(dimethylamino)phthalocyanine |  | C56H68N12OV | 詳情 | 供應商 | |
| 546-62-3 | 毛蕊花糖 | VERBASCOSE; α-d-galp-(1→6)-α-d-galp-(1→6)-α-d-galp-(1→6)-α-d-glup(1←→2)-β-d-fruf; α-D-Galp-(1-6)-α-D-Galp-(1-6)-α-D-Galp-(1-6)-α-D-Glup(1↔:2)-β-D-Fruf; β-D-Fructofuranosyl 6-O-[6-O-[6-O-(α-D-galactopyranosyl)-α-D-galactopyranosyl]-α-D-galactopyranosyl]-α-D-glucopyranoside; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxane-3,4,5-triol; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-dimethylol-tetrahydrofuran-2-yl]oxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-3,4,5-triol; Verbascose,α-D-Galp-(1→6)-α-D-Galp-(1→6)-α-D-Galp-(1→6)-α-D-Glup(12)-β-D-Fruf |  | C30H52O26 | 詳情 | 供應商 |
| 38176-02-2 | (+)-[3-cyano-3-(3,4-dimethoxyphenyl)hex-6-yl](5,6-dimethoxyphenethyl)methylammonium chloride; R(+)-VERAPAMIL MONOHYDROCHLORIDE MONOHYDRATE; Benzeneacetonitrile, a-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-a-(1-methylethyl)-, monohydrochloride, (aR)- (9CI); Benzeneacetonitrile, a-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-a-(1-methylethyl)-, monohydrochloride, (R)-; Dexverapamil monohydrochloride; LU 33925; NSC 632821; Benzeneacetonitrile, alpha-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-alpha-(1-methylethyl)-, monohydrochloride, (alphaR)-; Benzeneacetonitrile, alpha-[3-[[2-(3,4-dimethoxyphenyl)ethyl]-methylamino]propyl]-3,4-dimethoxy-alpha-(1-methylethyl)-, monohydrochloride, (R)- |  | C27H41ClN2O5 | 詳情 | 供應商 | |